Kontigo Care Q2’22: Strong sales and 16% EBIT margin
Redeye comments on Kontigo Care’s Q2’22 report where sales came in slightly higher than we estimated. The company continues to impress with solid revenue growth of 23% Y/Y and 8% Q/Q. This was the 9th consecutive report with net sales growth, continuing the solid growth path.
Sign up for free to continue
Already a member?
Disclosures and disclaimers
Premium Plan required to unlock